1 |
Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
DOI
ScienceOn
|
2 |
Chen HS, Su LT, Lin SZ, et al (2012). Increased risk of urinary tract calculi among patients with diabetes mellitus--a population-based cohort study. Urology, 79, 86-92.
DOI
ScienceOn
|
3 |
Chow WH, Lindblad P, Gridley G, et al (1997). Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst, 89, 1453-7.
DOI
ScienceOn
|
4 |
DerSimonian R, Laird N(1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
DOI
ScienceOn
|
5 |
Dunn SE, Kari FW, French J, et al (1997). Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res, 57, 4667-72.
|
6 |
Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
DOI
ScienceOn
|
7 |
Flegal KM, Graubard BI, Williamson DF, Gail MH (2005). Excess deaths associated with underweight, overweight, and obesity. JAMA, 293, 1861-7.
DOI
ScienceOn
|
8 |
Funfstuck R, Nicolle LE, Hanefeld M, Naber KG (2012). Urinary tract infection in patients with diabetes mellitus. Clin Nephrol, 77, 40-8.
DOI
|
9 |
Haggstrom C, Stocks T, Rapp K, et al (2011). Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). Int J Cancer, 128, 1890-8.
DOI
ScienceOn
|
10 |
Jankovic S, Radosavljevic V (2007). Risk factors for bladder cancer. Tumori, 93, 4-12.
|
11 |
Jee SH, Yun JE, Park EJ, et al (2008). Body mass index and cancer risk in Korean men and women. Int J Cancer, 123, 1892-6.
DOI
ScienceOn
|
12 |
Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
DOI
|
13 |
Jones ME, Swerdlow AJ (1998). Bias in the standardized mortality ratio when using general population rates to estimate expected number of deaths. Am J Epidemiol, 148, 1012-7.
DOI
ScienceOn
|
14 |
Key TJ, Appleby PN, Reeves GK, Roddam AW(2010). Insulinlike growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol, 11, 530-42.
DOI
ScienceOn
|
15 |
Koebnick C, Michaud D, Moore SC, et al (2008). Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev, 17, 1214-21.
DOI
ScienceOn
|
16 |
Larsson SC, Andersson SO, Johansson JE, Wolk A (2008). Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer, 44, 2655-60.
DOI
ScienceOn
|
17 |
Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.
DOI
ScienceOn
|
18 |
Mantel N, Haenszel W(1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
|
19 |
Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, et al (2007). Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol, 25, 285-95.
DOI
ScienceOn
|
20 |
Rinaldi S, Cleveland R, Norat T, et al (2010). Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer, 126, 1702-15.
|
21 |
Zhao H, Grossman HB, Spitz MR, et al (2003). Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol, 169, 714-7.
DOI
ScienceOn
|